Skip to main content
. 2021 Jul 16;9(7):831. doi: 10.3390/biomedicines9070831

Figure A3.

Figure A3

IL-17A does not significantly alter pJAK1 expression in ARPE-19 cells. Western blot (A) and corresponding (BD) densitometry analysis of pJAK1, JAK1 and β-actin. (E) Representative immunostaining for pJAK1 (red) in control (UT) and IL-17A-treated ARPE19 cells, and (F) corresponding quantification. UT: untreated control.